Landmark CRISPR trial shows promise against deadly disease | GEN SUISSE. https://gensuisse.ch/de/aktuell/landmark-crispr-trial-shows-promise-against-deadly-disease
Administering gene-editing treatment directly into the body could be a safe and effective way to treat a rare, life-threatening condition. Preliminary results from a landmark clinical trial suggest that CRISPR–Cas9 gene editing can be deployed directly into the body to treat disease.
November 2024 Der Beschluss eines Tierversuchsverbots könnte den wissenschaftlichen